BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 15902326)

  • 41. A model for oncology clinical indicators.
    Enck RE
    Cancer; 1989 Jul; 64(1 Suppl):306-9; discussion 314-6. PubMed ID: 2720621
    [No Abstract]   [Full Text] [Related]  

  • 42. [The possible role of the timing of the first oncological treatment on the survival rate of cancer diseases. A literature overview].
    Mangel L; Tornóczky T; Zemplényi A; Boncz I
    Orv Hetil; 2018 Apr; 159(14):535-546. PubMed ID: 29611749
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Multidisciplinary cancer clinics: their time has come.
    Chang AE
    J Surg Oncol; 1998 Dec; 69(4):203-5. PubMed ID: 9881935
    [No Abstract]   [Full Text] [Related]  

  • 44. How relevant is present cancer research?
    Br Med J; 1969 Jul; 3(5661):4-5. PubMed ID: 5787289
    [No Abstract]   [Full Text] [Related]  

  • 45. [Epidemiology of cancer in Hungary].
    Jugasz I
    Orv Hetil; 1975 Jan; 116(4):207-9. PubMed ID: 1110836
    [No Abstract]   [Full Text] [Related]  

  • 46. [NATIONAL BREAST CANCER STATISTICS].
    NAGY A
    Magy Onkol; 1964 Jun; 8():69-70. PubMed ID: 14160571
    [No Abstract]   [Full Text] [Related]  

  • 47. Cancer detection work in Hungary in the last the years.
    VIKOL J
    Acta Chir Acad Sci Hung; 1962; 3():i-vii. PubMed ID: 13997197
    [No Abstract]   [Full Text] [Related]  

  • 48. Multigene classifiers, prognostic factors, and predictors of breast cancer clinical outcome.
    Ross JS
    Adv Anat Pathol; 2009 Jul; 16(4):204-15. PubMed ID: 19546609
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Report on the first year of the activity of the National Oncological RD Consortium].
    Tímár J
    Magy Onkol; 2002; 46(4):297-300. PubMed ID: 12563351
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Developments in cancer management by innovative genomics. 2006 report of the National Cancer Consortium].
    Tímár J; Kásler M; Kátai J; Soós M; Mathiasz D; Romány A; Patthy L; Kovács G; Józsa A; Szilák L; Forrai T
    Magy Onkol; 2006; 50(4):349-59. PubMed ID: 17216011
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Report of the National Oncology Research and Developement Consortium, 2003].
    Tímár J
    Magy Onkol; 2004; 48(1):75-9. PubMed ID: 15105900
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Developments in cancer care with innovative genomics. 2008 report of the National Cancer Consortium].
    Tímár J; Kásler M; Heringh A; Soós M; Mathiász D; Romány A; Józsa A; Szilák L; Forrai T; Patthy L; Kovács G
    Magy Onkol; 2009 Dec; 53(4):321-34. PubMed ID: 20071304
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [The first 20 years of the Department of Molecular Genetics of the National Institute of Oncology (NIO)].
    Oláh E
    Magy Onkol; 2007; 51(2):89-94. PubMed ID: 17660864
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Activity of the National Oncology R&D Consortium in 2004].
    Tímár J;
    Magy Onkol; 2005; 49(1):3-7. PubMed ID: 15902326
    [TBL] [Abstract][Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.